Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UC

NCT02808390 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

19

Enrollment

OTHER

Sponsor class

Stopped Sponsor decision

Conditions

Ulcerative Colitis

Interventions

DRUG: GED-0507-34-Levo 80 mg
DRUG: GED-0507-34-Levo 160 mg
DRUG: Placebo

Sponsor

PPM Services S.A.